Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
zkab001 (1 trial)
gimatecan (1 trial)
Carcinoma (Phase 2)
Carcinoma, Ovarian Epithelial (Phase 1)
Carcinoma, Transitional Cell (Phase 2)
Fallopian Tube Neoplasms (Phase 1)
Peritoneal Neoplasms (Phase 1)
Trials (2 total)
Trial APIs (2 total)